Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BIO-RAD LABORATORIES, INC. Director's Dealing 2012

Jun 12, 2012

30786_dirs_2012-06-12_30243057-41f2-486a-9621-d577fa4bd42a.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIO RAD LABORATORIES INC (BIO, BIOB)
CIK: 0000012208
Period of Report: 2012-06-10

Reporting Person: SCHWARTZ NORMAN D (Director, CEO, 10% Owner)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2012-06-10 Bio-Rad B Common Stock M 2400 Acquired 94945 Direct
2012-06-10 Bio-Rad B Common Stock F 880 $96.58 Disposed 94065 Direct
2012-06-11 Bio-Rad B Common Stock F 917 $96.92 Disposed 93148 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2012-06-10 Restricted Stock Units $0 M 2400 Disposed Bio-Rad B Common Stock (2400) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Bio-Rad A Common Stock 411252 Direct
Bio-Rad B Common Stock 12146 Indirect
Bio-Rad B Common Stock 4060054 Indirect
Bio-Rad B Common Stock 13726 Indirect

Footnotes

F1: Shares of Class B common stock acquired on the vesting of restricted stock units.

F2: The reporting person disclaims beneficial ownership of these shares.

F3: The shares are held by a limited partnership of which the reporting person is a limited and general partner. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.

F4: The shares are held by a limited partnership of which the reporting person is a limited partner.

F5: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class B common stock.

F6: The restriced stock units vest in five equal annual installments beginning June 10, 2010.